As of 22 Sept 2026, Medicamen Biotech Ltd share price is ₹319.50. The stock opened at ₹319.50 and had closed at ₹314.40 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹210.10 and a high of ₹454.00. In terms of performance, Medicamen Biotech Ltd share price has increased by 32.35% over the past six months and has decreased by 5.88% over the last year.
MEDICAMEQ Stock Price Chart
Medicamen Biotech Ltd Overview
About MEDICAMEQ
Medicamen Biotech engaged in the research, development and manufacturing, and global marketing of Finished Dosage Forms (FDFs) and liquid formulations. MBL specializes in Oncology, Cardiovascular Diseases (CVD), Central Nervous System (CNS), Diabetology, Anti-Malarials, Antibiotics and Pain Managemen with an established presence across more than 35 countries in the Rest of the World (ROW) and an expanding footprint in highly regulated markets,
Medicamen Biotech Ltd Historical Performance
Medicamen Biotech Ltd Fundamentals
Medicamen Biotech Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 181.95 | 157.69 | 174.69 | 140.34 | 117.17 |
| EBITDA | 21.39 | 22.78 | 28.28 | 26.60 | 25.27 |
| Net Profit | 9.41 | 9.45 | 13.30 | 15.00 | 14.91 |
| EPS | 6.94 | 7.43 | 10.50 | 12.04 | 12.20 |
Medicamen Biotech Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 303.43 |
| Resistance 1 (R1) | 335.68 |
| Pivot Point | 324.72 |
Medicamen Biotech Ltd Dividend History
| Ex Date | Dividends Date | Record Date | Dividend Type | Dividend Details |
|---|---|---|---|---|
| 18-Sep-2026 | 27-May-2026 | 19-Sep-2026 | Final | ₹1.00 |
| 19-Sep-2025 | 30-May-2025 | 19-Sep-2025 | Final | ₹1.00 |
| 19-Sep-2024 | 29-May-2024 | 19-Sep-2024 | Final | ₹1.00 |
| 20-Sep-2023 | 29-May-2023 | 21-Sep-2023 | Final | ₹1.00 |
| 19-Sep-2022 | 25-May-2022 | 21-Sep-2022 | Final | ₹1.00 |
MEDICAMEQ Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Rahul Bishnoi | Chairman |
| Vimal Kumar Shrawat | Non Executive Independent Director |
| S K Singh | Non Executive Independent Director |
Medicamen Biotech Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,846.40-1.20% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,352.00-0.62% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,935.00-0.70% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Medicamen Biotech Ltd today is ₹319.50 on NSE and ₹319.50 on BSE.
- The 52-week high of Medicamen Biotech Ltd is ₹454.00, while the 52-week low is ₹210.10.
- The current market capitalisation of Medicamen Biotech Ltd is approximately ₹426 crore.
- The P/E (Price-to-Earnings) ratio of Medicamen Biotech Ltd is 57.06. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Medicamen Biotech Ltd is 1.49. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Medicamen Biotech Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for MEDICAMEQ on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Medicamen Biotech Ltd has delivered a return of approximately -52.97%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Medicamen Biotech Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 40.46% promoters, 0.07% FIIs, 0.40% DIIs, and 32.10% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
